ORIC Pharmaceuticals Inc

ORIC

Company Profile

  • Business description

    ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

  • Contact

    240 E. Grand Avenue
    2nd Floor
    South San FranciscoCA94080
    USA

    T: +1 650 388-5600

    https://www.oricpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    111

Stocks News & Analysis

stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.
stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,008.00157.40-1.72%
CAC 408,352.0016.91-0.20%
DAX 4026,598.64151.31-0.57%
Dow JONES (US)51,608.17739.38-1.41%
FTSE 10010,881.5521.01-0.19%
HKSE23,578.65175.19-0.74%
NASDAQ24,509.76626.52-2.49%
Nikkei 22558,956.67705.35-1.18%
NZX 50 Index14,350.6846.910.33%
S&P 5007,416.59145.08-1.92%
S&P/ASX 2008,892.00152.70-1.69%
SSE Composite Index3,591.8910.68-0.30%

Market Movers